Clemens Möller

Boston Consulting Group (United States)

Medicine · Health Sciences

23h-index3.7kcitations51works0.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Renal Diseases and Glomerulopathies(14), Force Microscopy Techniques and Applications(9), Lipid Membrane Structure and Behavior(8), Cardiac electrophysiology and arrhythmias(7), Chronic Kidney Disease and Diabetes(7)

Publications51 total

2025 FDA approvals: volume maintained, but value remains below average
Nature Reviews Drug Discovery·2026
Development, implementation and evaluation of a hybrid study program for sustainability competencies and future skills
Frontiers in Education·2025Open Access
2024 FDA approvals exceed average number but have lower sales projections
Nature Reviews Drug Discovery·2025· 1 cited
2023 FDA approvals: unprecedented volume at moderate value
Nature Reviews Drug Discovery·2024· 2 cited
Update on Toxicological and Safety Pharmacological Profiling of the Anti-Infective and Anti-Inflammatory Peptide Pep19-2.5
Vide Leaf, Hyderabad eBooks·2023Open Access
2022 FDA approval number dips: a COVID-19 hangover?
Nature Reviews Drug Discovery·2023· 3 cited
Toxicological and Safety Pharmacological Profiling of the Anti-Infective and Anti-Inflammatory Peptide Pep19-2.5
Microorganisms·2022· 3 citedOpen Access
Acute effects of the imidacloprid metabolite desnitro-imidacloprid on human nACh receptors relevant for neuronal signaling
Archives of Toxicology·2021· 59 citedOpen Access
Functional alterations by a subgroup of neonicotinoid pesticides in human dopaminergic neurons
Archives of Toxicology·2021· 69 citedOpen Access
Human neuronal signaling and communication assays to assess functional neurotoxicity
Archives of Toxicology·2020· 23 citedOpen Access
Proteolytic processing of dynamin by cytoplasmic cathepsin L is a mechanism for proteinuric kidney disease
UNC Libraries·2020Open Access
Innovation in Regulatory Science Is Meeting Evolution of Clinical Evidence Generation
Clinical Pharmacology & Therapeutics·2019· 24 citedOpen Access
Development of a microelectrode array (MEA) based neurotoxicity assay for detecting the seizurogenic activity of novel drug candidates
Frontiers in Cellular Neuroscience·2018Open Access
Novel screening techniques for ion channel targeting drugs
Channels·2015· 48 citedOpen Access
Reduction of Proteinuria through Podocyte Alkalinization
Journal of Biological Chemistry·2014· 21 citedOpen Access
Structure of the Kidney Slit Diaphragm Adapter Protein CD2-Associated Protein as Determined with Electron Microscopy
Journal of the American Society of Nephrology·2014· 10 citedOpen Access
Automated Planar Patch-Clamp
Methods in molecular biology·2013· 34 cited
CD2AP in mouse and human podocytes controls a proteolytic program that regulates cytoskeletal structure and cellular survival
Journal of Clinical Investigation·2012· 5 citedOpen Access
CD2AP in mouse and human podocytes controls a proteolytic program that regulates cytoskeletal structure and cellular survival
Journal of Clinical Investigation·2011· 141 citedOpen Access
Angiotensin II Contributes to Podocyte Injury by Increasing TRPC6 Expression via an NFAT-Mediated Positive Feedback Signaling Pathway
American Journal Of Pathology·2011· 207 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Jochen Reiser(14), Daniel J. Müller(11), Mehmet M. Altintas(9), Changli Wei(9), Andreas Engel(7), Sanja Sever(6), Dominik Loser(6), Timm Danker(6), Christian Faul(5), Jan Flesche(5), Dimitrios Fotiadis(5), Dontscho Kerjaschki(4), Tobias B. Huber(4), Udo Kraushaar(4), Simon Scheuring(4), Michael S. Ringel(4), Mathias Baedeker(4), Peter Mündel(3), Maria Pia Rastaldi(3), Matthias Kretzler(3)